BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8276798)

  • 1. Binding of recombinant fibrinogen mutants to platelets.
    Farrell DH; Thiagarajan P
    J Biol Chem; 1994 Jan; 269(1):226-31. PubMed ID: 8276798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fibrinogen alpha and gamma chain sites in platelet aggregation.
    Farrell DH; Thiagarajan P; Chung DW; Davie EW
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10729-32. PubMed ID: 1438269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads.
    Liu Q; Rooney MM; Kasirer-Friede A; Brown E; Lord ST; Frojmovic MM
    Biochim Biophys Acta; 1998 Jun; 1385(1):33-42. PubMed ID: 9630497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.
    Bayer AS; Sullam PM; Ramos M; Li C; Cheung AL; Yeaman MR
    Infect Immun; 1995 Sep; 63(9):3634-41. PubMed ID: 7642301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The residues AGDV of recombinant gamma chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation.
    Hettasch JM; Bolyard MG; Lord ST
    Thromb Haemost; 1992 Dec; 68(6):701-6. PubMed ID: 1287885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
    Bajt ML; Ginsberg MH; Frelinger AL; Berndt MC; Loftus JC
    J Biol Chem; 1992 Feb; 267(6):3789-94. PubMed ID: 1371279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen.
    Podolnikova NP; Yakubenko VP; Volkov GL; Plow EF; Ugarova TP
    J Biol Chem; 2003 Aug; 278(34):32251-8. PubMed ID: 12799374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation.
    Liu Q; Matsueda G; Brown E; Frojmovic M
    Biochim Biophys Acta; 1997 Dec; 1343(2):316-26. PubMed ID: 9434121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
    Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
    Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets.
    Mohri H; Ohkubo T
    Peptides; 1993; 14(2):353-7. PubMed ID: 8483813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS; Shattil SJ; Power JW; Gartner TK
    J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
    Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
    J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Peerschke EI; Francis CW; Marder VJ
    Blood; 1986 Feb; 67(2):385-90. PubMed ID: 3942829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Chen CS; Chou SH; Thiagarajan P
    Biochemistry; 1988 Aug; 27(16):6121-6. PubMed ID: 3191112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets.
    Savage B; Ruggeri ZM
    J Biol Chem; 1991 Jun; 266(17):11227-33. PubMed ID: 2040630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
    Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
    Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-fibrinogen interactions.
    Bennett JS
    Ann N Y Acad Sci; 2001; 936():340-54. PubMed ID: 11460491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A discrete sequence in a platelet integrin is involved in ligand recognition.
    D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF
    Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.